RTW Investments, LP 13D and 13G filings for ProQR Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 10:13 am Sale | 2022-12-31 | 13G | ProQR Therapeutics N.V. PRQR | RTW Investments, LP | 0 0.000% | -7,027,725 (Position Closed) | Filing |
| 2022-02-14 08:10 am Purchase | 2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR | RTW Investments, LP | 7,027,725 9.900% | 1,939,232 (+38.11%) | Filing |
| 2021-04-05 6:26 pm Purchase | 2021-02-01 | 13G | ProQR Therapeutics N.V. PRQR | RTW Investments, LP | 5,088,493 10.100% | 78,725 (+1.57%) | Filing |
| 2021-02-12 09:32 am Purchase | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | RTW Investments, LP | 5,009,768 9.260% | 230,633 (+4.83%) | Filing |